ThinkGenetic to Engage with Rare Disease Community at Global Genes’ 6th Annual RARE Patient Advocacy Summit

ThinkGenetic, Inc. is delighted to be participating in the 6th Annual RARE Patient Advocacy Summit and Partnering and Investor Forum to further its mission of empowering the rare disease community by reducing the time to a genetic diagnosis.

This is the first time ThinkGenetic has attended these events, both hosted by Global Genes. Key ThinkGenetic executive leadership will be involved in multiple activities, including investor presentations, speaking in a technologist innovations panel, exhibiting in the ThinkGenetic booth, meeting with key thought leaders and industry partners, and engaging with rare disease families.

To learn more about the event and events taking place, please scroll below.

2017 RARE Patient Advocacy Summit

The 2017 RARE Patient Advocacy Summit brings rare advocates from across the globe together to Connect, Collaborate, and Activate. This educational conference creates a space for members of the rare disease community to share best practices, create important introductions, and help catalyze powerful collaborations. Attendees share their experience, knowledge, and expertise as conference presenters and or participants.

• When: September 13-15, 2017
• Location: Irvine, California
• Venue: Hotel Irvine, 17900 Jamboree Road, Irvine, California 92614
• Agenda: Global Genes Website

ThinkGenetic Participation

 

Date	Time	Event
Wednesday, 09/13/2017	3:00 PM – 7:00 PM	ThinkGenetic, Inc. exhibiting in Exhibitor Pavilion
Thursday, 09/14/2017	6:30 AM – 5:30 PM	ThinkGenetic, Inc. exhibiting in Exhibitor Pavilion
Thursday, 09/14/2017	8:00 AM – 5:00 PM	“ThinkGenetic, Inc. – Global Genes RARE Partnering and Investor Forum,” presented by Dave Jacob and Dawn Jacob Laney
Friday, 09/15/2017	6:30 AM – 5:30 PM	ThinkGenetic, Inc. exhibiting in Exhibitor Pavilion
Friday, 09/15/2017	2:30 PM – 3:30 PM	“Artificial Intelligence: Making Research and Diagnosis Faster and More Accurate,” presented by Dave Jacob and Dekel Gelbman, CEO, FDNA.

 

ThinkGenetic’s leadership team in attendance welcomes meetings to discuss ideas and shared interests at the Rare Partnering and Investor Forum 2017. To schedule a one-on-one meeting, please click here.